Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,539 | -33,914 | -13,149 | -35,129 | 210 |
| Depreciation Amortization | 328 | 269 | 135 | 169 | 101 |
| Income taxes - deferred | 34 | 24 | 8 | 114 | 0 |
| Accounts payable and accrued liabilities | 191 | 2,083 | 398 | -163 | 1,365 |
| Other Working Capital | 3,665 | 4,811 | 1,197 | -126,319 | -152,167 |
| Other Operating Activity | 23,109 | 5,880 | 1,954 | 112,272 | 116,479 |
| Operating Cash Flow | $-37,212 | $-20,847 | $-9,457 | $-49,056 | $-34,012 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -94,621 | -70,860 | N/A | N/A | N/A |
| Sale Of Investment | 10,500 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 356 | 356 |
| Investing Cash Flow | $-84,121 | $-70,860 | $N/A | $356 | $356 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,410 | 40 | N/A | 69,443 | N/A |
| Other Financing Activity | -510 | -509 | 0 | 106,406 | 108,140 |
| Financing Cash Flow | $13,900 | $-469 | $N/A | $175,849 | $108,140 |
| Beginning Cash Position | 134,696 | 134,696 | 134,696 | 7,547 | 7,546 |
| End Cash Position | 27,263 | 42,520 | 125,239 | 134,696 | 82,030 |
| Net Cash Flow | $-107,433 | $-92,176 | $-9,457 | $127,149 | $74,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,212 | -20,847 | -9,457 | -49,056 | -34,012 |
| Free Cash Flow | -37,212 | -20,847 | -9,457 | -49,056 | -34,012 |